Paul W Jones (Paul Jones)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Topics

Chronic Obstructive Pulmonary Disease

Cross Sectional

Top Venues

International journal of chronic obstructive pulmonary disease

ERJ open research

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Paul W Jones, Osamu Hataji, Yoshimi Suzukamo, Bruce Crawford, Yoko Sakai, Takeo Ishii, Keiko Sato, Eri Sasaki, Kenichi Hashimoto, Toru Oga
Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan. COPD 20 (1) (2023)
David M G Halpin, Robyn Kendall, Soham Shukla, Alan A Martin, Dhvani Shah, Dawn Midwinter, Kai-Michael Beeh, Janwillem W H Kocks, Paul W Jones, Chris Compton, Nancy A Risebrough, Afisi S Ismaila
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Masahiro Shinoda, Osamu Hataji, Motohiko Miura, Masaharu Kinoshita, Akira Mizoo, Kazunori Tobino, Toru Soutome, Takanobu Nishi, Takeo Ishii, Bruce E Miller, Ruth Tal-Singer, Ryan Tomlinson, Taizo Matsuki, Paul W Jones, Yoko Shibata
A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study. International journal of chronic obstructive pulmonary disease 17 (2022)
Paul W Jones, Chanzheng Wang, Ping Chen, Liping Chen, Daoxin Wang, Junbo Xia, Yang Yang, Yingyu Wang, Qianli Ma
The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice. International journal of chronic obstructive pulmonary disease 17 (2022)
Janelle Yorke, Naimat Khan, Adam Garrow, Sarah Tyson, Dave Singh, Jorgen Vestbo, Paul W Jones
Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study. International journal of chronic obstructive pulmonary disease 17 (2022)
Bjermer Leif, Isabelle H Boucot, Claus F Vogelmeier, Francois Maltais, Paul W Jones, Lee Tombs, Chris Compton, David A Lipson, Edward M Kerwin
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial. Advances in therapy 38 (9) (2021)
Claus F Vogelmeier, Ian P Naya, Francois Maltais, Bjermer Leif, Edward M Kerwin, Lee Tombs, Paul W Jones, Chris Compton, David A Lipson, Isabelle H Boucot
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement. International journal of chronic obstructive pulmonary disease 16 (2021)
Bjermer Leif, Isabelle H Boucot, Francois Maltais, Edward M Kerwin, Ian P Naya, Lee Tombs, Paul W Jones, Chris Compton, David A Lipson, Claus F Vogelmeier
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial. International journal of chronic obstructive pulmonary disease 16 (2021)
Soham Shukla, Dhvani Shah, Alan A Martin, Nancy A Risebrough, Robyn Kendall, Claus F Vogelmeier, Isabelle H Boucot, Lee Tombs, Bjermer Leif, Paul W Jones, Edward M Kerwin, Chris Compton, Francois Maltais, David A Lipson, Afisi S Ismaila
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model. International journal of chronic obstructive pulmonary disease 16 (2021)
Hyun-Il Gil, Sungmin Zo, Paul W Jones, Bo-Guen Kim, Noeul Kang, Yeonseok Choi, Hyun Kyu Cho, Danbee Kang, Juhee Cho, Hye Yoon Park, Sun Hye Shin
Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Study. International journal of chronic obstructive pulmonary disease 16 (2021)
Zhenyu Liang, Nanshan Zhong, Rongchang Chen, Qianli Ma, Yongchang Sun, Fuqiang Wen, Ruth Tal-Singer, Bruce E Miller, Julie Yates, Jie Song, Chris Compton, Beulah Ji, Li Wu, Yang Yang, Paul W Jones, Jinping Zheng
Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale. ERJ open research 7 (3) (2021)
Nobuyuki Hizawa, Koichi Fukunaga, Hisatoshi Sugiura, Yasutaka Nakano, Motokazu Kato, Yutaro Sugiyama, Tomohiro Hanazawa, Toshihiko Kaise, Ruth Tal-Singer, Paul W Jones, Neil C Barnes, Chris Compton, Takeo Ishii
A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design. International journal of chronic obstructive pulmonary disease 16 (2021)
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss, David M G Halpin
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International journal of chronic obstructive pulmonary disease 16 (2021)
Hannah B Lewis, Melanie Schroeder, Necdet B Gunsoy, Ellen M Janssen, Samuel Llewellyn, Helen A Doll, Paul W Jones, Afisi S Ismaila
Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany. International journal of chronic obstructive pulmonary disease 15 (2020)
Catherine A Spilling, Mohani-Preet K Bajaj, Daniel R Burrage, Sachelle Ruickbie, Ngoc Jade Thai, Emma H Baker, Paul W Jones, Thomas R Barrick, James William Dodd
Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function. International journal of chronic obstructive pulmonary disease 14 (2019)
Paul W Jones, Hana Mullerova, Alvar Agusti, Marc Decramer, Lukasz Adamek, Alice Raillard, Chang-Qing Zhu, Jadwiga A Wedzicha
Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine 197 (3) (2019)